Emphasis on the prevention and treatment of hepatic vascular diseases
10.3760/cma.j.cn501113-20221202-00589
- VernacularTitle:重视肝脏血管性疾病的防治
- Author:
Chengwei TANG
1
Author Information
1. 四川大学华西医院消化内科，成都 610041
- Keywords:
Liver cirrhosis;
Portal hypertension;
Transjugular intrahepatic portosystemic shunt;
Portal vein thrombosis;
Hepatic sinus obstruction syndrome;
Magnetic a
- From:
Chinese Journal of Hepatology
2022;30(12):1289-1291
- CountryChina
- Language:Chinese
-
Abstract:
Portal hypertension, as a common and complex hepatic vascular disease, is a key pathophysiological link in many events of acute cirrhosis decompensation and the progression of multiple organ failure. The most effective measure to reduce portal hypertension is a transjugular intrahepatic portosystemic shunt (TIPS). Maintaining liver function, reducing complications, and improving patients' quality of life and survival time are positively impacted by early TIPS insertion. Patients with cirrhosis have a risk of portal vein thrombosis (PVT) that is 1 000 times higher than that of the normal population. Hepatic sinusoidal obstruction syndrome has a severe clinical course and a high mortality risk. The primary treatment approaches for PVT and HSOS are anticoagulation and TIPS. The innovative magnetic anastomosis vascular technique significantly shortens the anhepatic time and restores normal liver function in patients following liver transplantation.
